The Effect On Self-Care and Self-Efficacy of Inhaler Training in COPD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-01

Study Completion Date

2018-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of planned inhaler medication training on self-care agency and self-efficacy level.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Education Based on the Chronic Care Model in COPD Patients

NCT05029557

Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Self-Management +1 more

COMPLETED NA

Effectiveness of Education Given to Patients With COPD

NCT05577897

COPD

COMPLETED NA

Evaluation of the Effect of Web-designed Training Developed for Asthma Patients

NCT04607681

Asthma

COMPLETED NA

Effect of Education and Tele-consultancy Intervention Based on Watson Human Care Theory Individuals With COPD

NCT04256070

Chronic Obstructive Pulmonary Disease Self Efficacy Quality of Life +2 more

COMPLETED NA

The Effect of Mobile Online Training Applied to Patients With Diabetes on Insulin Therapy

NCT05787067

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulmonary diseases are a major source of mortality and morbidity globally. The major symptom of COPD is dyspnea. Since dyspnea leads to activity limitation and inadequate self-care skills among individuals, it is often associated with major psychological comorbidity, social isolation and poor perceived quality of life. COPD patients with high self-efficacy are high enough to level of treatment adherence. On the other hand, the most preferred treatment method for the management and mitigation of COPD symptoms is by the use of inhaler medication. However, incorrect use of the inhaler would lead to failure in the control of COPD patients. Also, it fails to provide COPD patients with self-care agency and self-efficacy levels. In COPD, planned inhaler medication training has been shown in many studies to reduce dyspnoea, increase self-care and self-efficacy levels. Therefore, planned inhaler medication training increases quality of life in COPD patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

Planned Inhaler Medication Training

Group Type EXPERIMENTAL

Training

Intervention Type OTHER

Planned Inhaler Medication Trainning

Control Group

usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training

Planned Inhaler Medication Trainning

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who are literate,
* Diagnosed with COPD at least six months ago,
* Using inhaler medication since three or more months,
* Moderate or severe COPD, according to GOLD criteria,
* Incorrect use inhaler medication uses according to the list of inhaler medication use skills,
* No communication problems,
* No mental confusion or any psychiatric problem,
* Agrees to participate in the study.

Exclusion Criteria

* Cognitive dysfunction,
* Severe pulmonary, cardiological or malignant disease,
* In a period of exacerbation,
* Correctly performs all steps for their prescribed inhaler medication(s), according to the list of inhaler skills.

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No